Mektovi BINIMETINIBCo-Marketing Agreement • March 1st, 2022
Contract Type FiledMarch 1st, 2022This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.